Clinical Trial Update: CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating CT-322 in combination with radiation therapy and temozolomide for newly diagnosed glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• CT-322
• Temozolomide (Temozolomide)

Snippet

Sponsor: Adnexus, A Bristol-Myers Squibb R&D Company | Conditions: Glioblastoma Multiforme | Phase 1 | Status: UNKNOWN